心臓バイオマーカーの世界市場2023年-2033年:予測・動向・分析・競争状況

◆英語タイトル:Cardiac Biomarkers Market Analysis By Product (Creatine Kinase, Troponins, Myoglobin, Natriuretic Peptides, Ischemia Modified Albumin (IMA)), By Application (Myocardial Infarction, Acute Coronary Syndrome (ACS), Congestive Heart Failure, Atherosclerosis), By Location of Testing (Point-of-care Testing, Laboratory Testing) & By Region – Global Market Insights 2023 to 2033

FactMRが発行した調査報告書(FACT23OCT080)◆商品コード:FACT23OCT080
◆発行会社(リサーチ会社):FactMR
◆発行日:2023年8月
◆ページ数:約170
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧、印刷不可)USD4,500 ⇒換算¥684,000見積依頼/購入/質問フォーム
Global Site License(同一拠点内共有可)USD8,500 ⇒換算¥1,292,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

心臓バイオマーカー市場 - レポートの範囲
Fact.MRによる心臓バイオマーカー市場に関する最新調査レポートは、2023年から2033年までの10年間の予測を提供しています。この調査では、現在市場の成長を決定している重要なトレンドを分析しています。本レポートでは、心臓バイオマーカーの提供に関連する主要なステークホルダーや新興企業とともに、主要な市場プレイヤーの促進要因、阻害要因、機会などの重要なダイナミクスについて解説しています。
また、予測期間における心臓バイオマーカー市場の将来状況に影響を与える原動力も提供しています。地域市場全体のバリューチェーン分析、ビジネス遂行、サプライチェーン分析に関する詳細な評価を掲載しています。
製品ポートフォリオ、主要戦略、SWOT分析とともに、心臓バイオマーカー市場で事業を展開する著名企業のリストは、この包括的な調査研究の信頼性を高めています。

レポート概要

本調査では、心臓バイオマーカーの生産能力、需要、製品開発、収益創出、全世界での販売など、多様な特徴に関する包括的な分析を提供しています。
予測期間中の心臓バイオマーカーの売上高を考慮し、楽観的シナリオと保守的シナリオを通じて市場の包括的な予測を提供。また、世界平均価格との地域別価格比較も考察しています。

市場規模評価に関する分析

市場は各セグメントごとに金額(US$ Mn)で分析されています。
世界および地域レベルでの心臓バイオマーカーの推定値は、金額ベース「US$ Mn」で入手可能です。市場の魅力度評価とともに、顕著な市場セグメントに関する前年比成長コントラストをレポートに組み込んでいます。さらに、全セグメントの絶対ドル機会分析が報告書に脚光を浴びています。
絶対ドル機会は、世界の心臓バイオマーカー市場における販売と流通の観点を考慮し、潜在的なリソースの特定とともに、メーカー/ディストリビューターが達成できる機会のレベルを評価する上で重要な役割を果たします。

地域セグメントに関する検査評価

本レポートでは、地域市場に関する予測を提供するのに役立つ主要なセクションを詳しく説明しています。これらの章には、予測期間中に心臓バイオマーカー市場の成長に重大な影響を与えると予想される地域マクロ(政治、経済、ビジネス環境の見通し)が含まれています。
各地域の心臓バイオマーカー需要に関する国別評価を、市場規模の推定と予測、価格指数、地域と国の隆盛の力学の影響分析とともに提供。また、すべての地域市場について、前年比成長率の予測もレポートに組み込んでいます。
また、新興国の金額と数量の詳細な内訳もレポートに含まれています。

競合に関する詳細分析

本レポートでは、心臓バイオマーカーの主要メーカーについて、その詳細なプロフィールとともに明らかにしています。を提供する主要な市場参入企業に関連する重要かつ最新のデータを、詳細なダッシュボードビューの助けを借りて提供しています。本レポートで提供される著名企業の市場シェア分析と比較は、レポート読者がビジネスを進める上で先手を打つことを可能にします。
各プレイヤーの包括的なSWOT分析とともに、製品ポートフォリオや主要戦略などの要点を含む企業プロフィールを掲載しています。企業のプレゼンスはマッピングされ、すべての著名なプレーヤーのマトリックスを通して提示され、したがって、読者に実用的な洞察を提供し、思慮深く市場の状況を提示し、心臓バイオマーカードメインにおける競争レベルを予測するのに役立ちます。

1.エグゼクティブサマリー
2.市場概要
3.市場リスク・動向分析
4.市場背景・基礎データポイント
5.世界心臓バイオマーカーの需要分析・予測
6.世界の心臓バイオマーカー市場分析・予測:用途別
7.世界の心臓バイオマーカー市場分析・予測:製品別
8.世界の心臓バイオマーカー市場分析・予測:検査場所別
9.世界の心臓バイオマーカー市場分析・予測:地域別
10.北米の心臓バイオマーカー市場分析・予測
11.中南米の心臓バイオマーカー市場分析・予測
12.ヨーロッパの心臓バイオマーカー市場分析・予測
13.東アジアの心臓バイオマーカー市場分析・予測
14.南アジア・オセアニアの心臓バイオマーカー市場分析・予測
15.中東・アフリカの心臓バイオマーカー市場分析・予測
16.市場構造分析
17.競合分析
18.仮定・略語
19.調査方法

❖ レポートの目次 ❖

1. Global Market – Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Cardiac Biomarkers

        3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices

        3.1.3. COVID-19 Impact Benchmark with Previous Crisis

            3.1.3.1. Change in Demand

            3.1.3.2. Before and After COVID-19 Crisis (Projected)

            3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)

            3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)

        3.1.4. Impact on Market and Value (US$ Mn)

            3.1.4.1. Likely Loss of Value in 2022

            3.1.4.2. Mid-term and Long Term Forecast

            3.1.4.3. Quarter by Quarter Demand and Recovery Assessment

        3.1.5. Anticipated Demand and Value Recovery Curve

            3.1.5.1. Likelihood of U-Shape Recovery

            3.1.5.2. Likelihood of L-Shape Recovery

        3.1.6. Recovery Period Assessment by Key Countries

        3.1.7. Recovery Assessment by Key Market Segments

        3.1.8. Action Points and Recommendations for Suppliers

        3.1.9. Impact on Trade Balance

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Source Development Trends

4. Market Background and foundation Data Points

    4.1. Need of the Hour for Industries

    4.2. Industry Wise Industry 4.0

    4.3. Strategic Priorities

    4.4. Life Cycle Stage

    4.5. Importance of Technology

    4.6. Use Cases of Cardiac Biomarkers

    4.7. Forecast Factors: Relevance and Impact

    4.8. Investment Feasibility Matrix

    4.9. PESTLE Analysis

    4.10. Porter’s Five Forces Analysis

    4.11. Market Dynamics

        4.11.1. Drivers

        4.11.2. Restraints

        4.11.3. Opportunity Analysis

        4.11.4. Trend

5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033

    5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022

    5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Myocardial Infarction

        6.3.2. Acute Coronary Syndrome (ACS)

        6.3.3. Congestive Heart Failure

        6.3.4. Atherosclerosis

    6.4. Market Attractiveness Analysis By Application

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Product, 2018 to 2022

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2023 to 2033

        7.3.1. Creatine Kinase

        7.3.2. Troponins

        7.3.3. Myoglobin

        7.3.4. Natriuretic Peptides

        7.3.5. Ischemia Modified Albumin (IMA)

    7.4. Market Attractiveness Analysis By Product

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Location of Testing

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Analysis By Location of Testing, 2018 to 2022

    8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Location of Testing, 2023 to 2033

        8.3.1. Point-of-care Testing

        8.3.2. Laboratory Testing

    8.4. Market Attractiveness Analysis By Location of Testing

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022

    9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Oceania

        9.3.6. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        10.3.1. By Country

            10.3.1.1. United States

            10.3.1.2. Canada

        10.3.2. By Application

        10.3.3. By Product

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Application

        10.4.3. By Product

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Application

        11.3.3. By Product

        11.3.4. By Location of Testing

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Application

        11.4.3. By Product

        11.4.4. By Location of Testing

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. France

            12.3.1.3. Italy

            12.3.1.4. Spain

            12.3.1.5. United Kingdom

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By Application

        12.3.3. By Product

        12.3.4. By Location of Testing

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Application

        12.4.3. By Product

        12.4.4. By Location of Testing

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. China

            13.3.1.2. Japan

            13.3.1.3. South Korea

        13.3.2. By Application

        13.3.3. By Product

        13.3.4. By Location of Testing

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Application

        13.4.3. By Product

        13.4.4. By Location of Testing

14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Malaysia

            14.3.1.4. Singapore

            14.3.1.5. Vietnam

            14.3.1.6. ANZ

            14.3.1.7. Rest of South Asia & Oceania

        14.3.2. By Application

        14.3.3. By Product

        14.3.4. By Location of Testing

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Application

        14.4.3. By Product

        14.4.4. By Location of Testing

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. GCC Countries

            15.3.1.2. South Africa

            15.3.1.3. Israel

            15.3.1.4. Rest of Middle East and Africa (MEA)

        15.3.2. By Application

        15.3.3. By Product

        15.3.4. By Location of Testing

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Application

        15.4.3. By Product

        15.4.4. By Location of Testing

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. Abbott

            17.3.1.1. Company Overview

            17.3.1.2. Source overview

            17.3.1.3. SWOT Analysis

            17.3.1.4. Key Developments

        17.3.2. Siemens Healthineers

            17.3.2.1. Company Overview

            17.3.2.2. Source overview

            17.3.2.3. SWOT Analysis

            17.3.2.4. Key Developments

        17.3.3. Randox Laboratories Ltd.

            17.3.3.1. Company Overview

            17.3.3.2. Source overview

            17.3.3.3. SWOT Analysis

            17.3.3.4. Key Developments

        17.3.4. Life Diagnostics

            17.3.4.1. Company Overview

            17.3.4.2. Source overview

            17.3.4.3. SWOT Analysis

            17.3.4.4. Key Developments

        17.3.5. Creative Diagnostics

            17.3.5.1. Company Overview

            17.3.5.2. Source overview

            17.3.5.3. SWOT Analysis

            17.3.5.4. Key Developments

        17.3.6. Quidel Corporation

            17.3.6.1. Company Overview

            17.3.6.2. Source overview

            17.3.6.3. SWOT Analysis

            17.3.6.4. Key Developments

        17.3.7. F. Hoffmann-La Roche Ltd.

            17.3.7.1. Company Overview

            17.3.7.2. Source overview

            17.3.7.3. SWOT Analysis

            17.3.7.4. Key Developments

        17.3.8. Biomerieux SA

            17.3.8.1. Company Overview

            17.3.8.2. Source overview

            17.3.8.3. SWOT Analysis

            17.3.8.4. Key Developments

        17.3.9. Bio-Rad Laboratories

            17.3.9.1. Company Overview

            17.3.9.2. Source overview

            17.3.9.3. SWOT Analysis

            17.3.9.4. Key Developments

        17.3.10. Danaher Corporation

            17.3.10.1. Company Overview

            17.3.10.2. Source overview

            17.3.10.3. SWOT Analysis

            17.3.10.4. Key Developments

18. Assumptions And Acronyms Used

19. Research Methodology

Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2022

Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2023 to 2033

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033

Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 07: Global Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022

Table 08: Global Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 16: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022

Table 17: North America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033

Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 22: North America Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022

Table 23: North America Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 28: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022

Table 29: Latin America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033

Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 34: Latin America Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022

Table 35: Latin America Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 40: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2022

Table 41: Europe Market Value (US$ Mn) Analysis, by Application, 2023 to 2033

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033

Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 46: Europe Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022

Table 47: Europe Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 52: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2022

Table 53: East Asia Market Value (US$ Mn) Analysis, by Application, 2023 to 2033

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033

Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 58: East Asia Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022

Table 59: East Asia Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2022

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2023 to 2033

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 76: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2022

Table 77: MEA Market Value (US$ Mn) Analysis, by Application, 2023 to 2033

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033

Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 82: MEA Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022

Table 83: MEA Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心臓バイオマーカーの世界市場2023年-2033年:予測・動向・分析・競争状況(Cardiac Biomarkers Market Analysis By Product (Creatine Kinase, Troponins, Myoglobin, Natriuretic Peptides, Ischemia Modified Albumin (IMA)), By Application (Myocardial Infarction, Acute Coronary Syndrome (ACS), Congestive Heart Failure, Atherosclerosis), By Location of Testing (Point-of-care Testing, Laboratory Testing) & By Region – Global Market Insights 2023 to 2033)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆